
Currently out of the existing stock ratings of Joon Lee, 222 are a BUY (89.16%), 27 are a HOLD (10.84%).
Analyst Joon Lee, currently employed at TRUIST, has had 51.44% of price targets met with an average potential upside of 63.23%, reached in 268 days on average.
Joon Lee has documented 489 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 11-Mar-2026.
Analyst best performing recommendations are on CORT (CORCEPT THERAPEUTICS).
The best stock recommendation documented was for CORT (CORCEPT THERAPEUTICS) on 8/2/2023. The price target of $29 was fulfilled within 1 day with a profit of $3.99 (15.95%), with a performance score of 159.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Apr-2024
$5
1 years 1 days ago
(17-Nov-2025)
0/6 (0%)
$0.73 (17.10%)
Buy Since 28-Apr-2020
$5.5
$12
1 years 20 days ago
(29-Oct-2025)
1/8 (12.5%)
$1.27 (30.02%)
366
Hold Since 16-Apr-2025
$4
$5
1 years 21 days ago
(28-Oct-2025)
1/2 (50%)
$-0.26 (-6.10%)
168
Buy Since 18-Jul-2024
1 years 3 months 5 days ago
(13-Aug-2025)
0/2 (0%)
$30.52 (321.94%)
Hold Since 11-Nov-2022
$4
$5
1 years 6 months 3 days ago
(15-May-2025)
4/9 (44.44%)
$1.95 (95.12%)
102
What Year was the first public recommendation made by Joon Lee?